Blog

Biogen says Tecfidera sales slow, delays data readout on Alzheimer's drug

The U.S. biotechnology company posted lower-than-expected quarterly profit and revenue, saying Tecfidera’s “challenging” quarter was hit by an overall slowdown in the MS market, which has been weighed down by discounting, a single case of a serious brain infection, and the effect of a stronger dollar. A number of patients are switching to the Biogen’s recently launched interferon-based MS drug Plegridy, which has also eaten into Tecfidera sales. If Tecfidera’s

U.N. welcomes EU migrant plan, says test is whether lives saved

By Stephanie Nebehay GENEVA (Reuters) – The United Nations on Friday welcomed the European Union’s plan to triple the size of its naval search mission in the Mediterranean, but said the key test was whether lives were saved and war refugees gained asylum. The EU’s assurances meant the operation would have capacity, resources and scope comparable to Italy’s Mare Nostrum rescue operation, which was ended six months ago, the U.N.

Children of depressed mothers at risk for behavior problems

By Lisa Rapaport (Reuters Health) – Children are more likely to develop behavioral or emotional problems if their mothers are chronically depressed, even if symptoms aren’t severe, a French study finds. While previous research has linked clinical depression in mothers to mood disorders and other health problems in their children, the current study is among the first to make this connection even when mothers have milder symptoms that might not